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 Summary
	   Frontotemporal	dementia	is	the	third	most	common	degenerative	condition	(after	Alzheimer	Disease	
and	Lewy	Body	Disease)	of	the	brain.	It	occurs	predominantly	after	the	age	of	40	and	usually	before	
the	 age	 of	 65,	with	 equal	 incidence	 in	men	 and	women.	Unspecific	 behavioral	 symptoms	 often	
lead	to	misdiagnosis	and	FTD	remains	undetected.	As	in	other	degenerative	dementias,	there	is	no	
specific	 tissue	marker;	 therefore,	 the	diagnosis	 is	 established	 in	vivo	on	 the	basis	 of	 clinical	 and	
radiological	 examinations.	 Structural	 and	 functional	neuroimaging	modalities	 are	most	useful	 in	
detection	and	differentiation	of	FTD	as	the	findings	are	specific	enough	to	be	considered	as	criteria,	
based	on	which	the	diagnosis	of	this	disorder	can	be	established.
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Background
Frontotemporal	dementia	 (FTD),	 in	 literature	also	 referred	




nerative	 states,	 in	which	 the	disease	process	 affects	with	
more	or	less	asymmetry	the	frontal	and/or	temporal	lobes.	
Regarding	the	neuropathological	lesions,	FTD	is	divided	to	
tauopathies	 and	 syndromes	without	 tau	protein	 aggrega-
tion	 in	brain.	As	 for	 genetics,	 FTD	 is	 also	heterogeneous.	
In	 about	 30-50%	 of	 cases	 FTD	 is	 familial	 and	 is	 usually	
inherited	 in	an	autosomal	dominant	way,	 including	small	
number	 of	 cases	 of	 fronto-temporal dementia with par-
kinsonism linked to chromosome 17	 (FTDP-17)	 caused	by	




In	 clinical	 presentation,	we	mark	 out	 3	main	 syndromes	
depending	on	topography:	
•		frontotemporal	 dementia	 with	 dominating	 behavioral	
disorders,	also	referred	to	as	frontal variant FTD (fvFTD)
•		frontotemporal	 dementia	with	 dominating	 verbal	 disor-
ders,	also	referred	to	as	temporal variant FTD (tvFTD),	in	
other	words:	semantic	dementia	(SD)
•		progressive non-fluent aphasia	 (PNFA),	 which	 is	 least	
	frequent	
In	FTD	diagnosing,	not	only	the	presence	of	typical	clinical	
symptoms	 is	 important,	 but	 also	 the	 result	 of	 structural	
and/or	 functional	 neuroimaging	 examinations.	 They	 are	
one	 of	 the	most	useful	 diagnostic	methods	 for	 confirma-
tion	 of	 the	 diagnosis	 based	 on	 clinical	 image,	 as	well	 as	
for	 canceling	 out	 particular	 symptomatic	 causes	 of	 cog-
nitive	 disorders,	 such	 as	 tumors,	 chronic	 posttraumatic	
hematomas	 or	 dilatation	 of	 ventricular	 system	 in	 course	
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of	Hakim’s	syndrome.	These	examinations	are	also	essen-
tial	 for	 differentiation	 from	 vascular	 dementia,	 parti-













by	 an	 alarmed	 family	 as	 then	patient	himself	 is	 unaware	













are	 characteristic.	 Lack	 of	 empathy	 is	 one	 of	 the	 earliest	
symptoms.	 In	some	cases	on	a	 later	 stage	we	can	observe	
elements	 of	Klüver–Bucy`s	 syndrome	which	 is	 caused	by	
affected	 anterior	 parts	 of	 both	 temporal	 lobes	 (change	 in	
dietetic	 likings,	 usually	 to	 sweets,	 hyperorality,	 increase/
decrease	in	sexual	activity).
Language	 disorders	 consist	 in	 vocabulary	 deficits	 leading	
to	 anomia,	 with	 preserved	 understanding	 of	 speech	 and	
repeating.	
Frontotemporal dementia – temporal variant (tvFTD) – semantic 
dementia
The	atrophy	concerns	mainly	the	anterior	parts	of	temporal	









One	 of	 the	 typical	 features	 is	 fluent	 speech	with	 tenden-
cy	 to	 loquacity,	 with	 simultaneous	 deficits	 in	 vocabu-





described	 in	 fvFTD.	Lack	of	 the	ability	 to	understand	and	
express	emotions	is	a	typical	symptom	resulting	from	atro-
phy	of	the	right	amygdaloid	body	[8].	
Progressive non-fluent aphasia (PNFA)
The	 syndrome	 is	 etiologically	diversified;	 in	 about	 50%	of	
cases	 the	 diagnosis	 based	 on	neuropathological	 examina-
tion	 is	 the	Alzheimer’s	disease	 [9].	Brain	atrophy	 is	asym-
metric	 and	affects	 left	 temporal	 and	 frontal	 lobe.	Patients	
with	PNFA	present	 lack	 of	 speech	 fluency	with	preserved	
understanding.	Their	 utterances	 are	 grammatically	 incor-
rect,	with	dominating	 signs	of	 omission	and	mistaken	use	
of	 prepositions	 and	 paraphasia.	 They	 have	 difficulties	 in	
repeating,	 reading	and	writing.	At	 first,	 the	 leading	symp-
tom	 is	 selective	 verbal	 unspontaneity.	 Speech	 apraxia	 is	
connected	with	involvement	of	insula	[10].




Neurological	 symptoms	 include:	 at	 an	 early	 stage-	 often	
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Neuropsychological examination
In	 clinical	 variants	with	dominating	 speech	disorders	 the	










Usually	 requires	differentiation	with	FTD.	Occurs	 in	 senior	
age,	memory	disorders	are	the	first	symptom	and	behavioral	
disorders	manifest	later.	Also	the	ability	to	live	on	their	own	
is	 lost	 gradually,	with	 time,	 along	with	 growing	dementia,	
while	FTD	patients	lose	it	early	due	to	the	type	of	cognitive	
and	behavioral	disorders.	Stereotypies,	perseverances,	disin-
hibition,	 uncontrollable	 eating,	 low	 social	 consciousness,	
neglecting	oneself,	apathy	and	impulsiveness	are	often	men-
tioned	as	most	differentiating	between	FTD	and	AD	[12].






Patients	 with	 VaD	 caused	 by	 multiple	 lacunar	 ischemic	
focuses	 can	manifest	 clinical	 symptoms	 similar	 to	 those	
typical	for	FTD.	Another	confusing	factor	is	the	slow	course	
(instead	of	fast)	of	the	disease	and	lack	of	stroke	in	clinical	






ved	 to	 be	 ineffective	 in	 treating	 the	 disordered	 cognitive	
functions	and	behavioral	disorders	are	in	some	cases	inten-
sified	by	them.	
Difficulties	 in	neurotransmission	 in	 serotoninergic	 system	
observed	 in	FTD	are	 responsible	 for	 impulsiveness,	 irrita-
bility,	changes	in	mood	and	diet	routine.	Hence	there	were	
attempts	 to	 apply	 selective	 inhibitors	 of	 serotonin	uptake	
in	FTD	in	order	to	control	behavioral	disorders.	They	were	
open	examinations	performed	on	small	groups	of	patients.	
Fluoxetine,	 sertraline	 or	 paroxetine	 taken	 by	 11	 patients	
for	 3	 months	 gave	 improvement	 in	 disinhibition	 (6/9	
patients),	voracity	(5/9),	compulsion	(4/7)	and	depression	in	
9	patients	[13].	






lower	 intensity	of	 illusions,	aggression,	 fear	and	 irritabili-





valproic	 acid)	 and	 antipsychotic	 drugs	 are	widely	used	 to	
control	 the	 FTD	 agitation.	 Due	 to	 the	 safety	 profile,	 the	
drugs	chosen	from	the	latter	group	should	be	drugs	of	the	
new	generation	[15].	
People	 taking	 care	 of	 FTD	patients	 are	 subject	 to	 no	 less	
burden	 than	 those	who	 look	 after	 AD	 patients,	 although	
some	believe	that	the	burden	is	even	bigger	for	FTD.	They	




1. Structural CT, MR
Structural	 FTD	 examinations	 show	 typical	 topography	 of	
atrophy	which	includes	a	more	or	less	symmetrical	selecti-
ve	atrophy	in	anterior	frontal	and/or	temporal	lobes	(fig.	1,	
2/3).	 Classic	 FTD	 image	 is	 presented	 as	 a	mixed	 atrophy	
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in	 clinical	 criteria	 of	 the	 disease	 [16].	On	 the	 other	 hand,	
it	 needs	 to	be	 emphasized	 that	 lack	 of	 atrophy	 in	 clinical	
suspicion	of	FTD	does	not	cancel	out	such	diagnosis.	
In	 frontal	 variant	 of	 FTD	 the	 atrophy	 is	 usually	 bilateral	
(fig.	4);	 in	PNFA	the	atrophy	is	 left-sided	and	asymmetrical,	
initially	 limited	 to	 the	 anterior	 temporal	 lobe	 and	 then	
involving	 the	 left	 (dominating)	 hemisphere,	while	 in	 SD-	
asymmetric	 atrophy	 of	 anterior	 parts	 of	 both	 temporal	
lobes	[17].	More	detailed	volumetric	examinations	in	mag-
netic	 resonance	 (voxel-based	morphometry)	 [18,	 19,	20]	
in	 fvFTD	 showed	atrophy	of	 orbital,	 dorsolateral	 frontal	
lobe,	cingulate	gyrus,	insula	and	dorsolateral	frontal	lobe,	
usually	visible	better	on	the	right	side.	In	PNFA	the	result	
was	 visualized	 better	 on	 the	 left	 and	 involved	 orbital	
gyrus	 of	 frontal	 lobe,	 cingulate	 gyrus,	 insula	 and	dorso-
lateral	 frontal	 lobe,	while	 in	 tvFTD	 the	 atrophy	affected	
orbital	 gyruses,	 anterior	 temporal	 lobe,	 amygdala	 and	
anterior	part	of	insula.
In	the	semantic	type	of	dementia	(fig.	5)	the	atrophy	is	often	
larger	 than	 in	 patients	with	Alzheimer’s	 disease	 and	 can	
involve	medial	structures	of	temporal	lobe,	but	usually	it	is	
more	symmetrical	and	is	accompanied	by	elevated	atrophy	
within	 the	 amygdala,	 pole	 of	 the	 temporal	 lobe,	 piriform	
gyrus	and	inferior-lateral	temporal	gyrus	[21].
2. Functional examinations: Single photon emission computed 
tomography (SPECT), positron emission tomography (PET)
























































































of	 varied	 intensity	 in	 frontal	 lobes	 and	 anterior	 temporal	
lobes	(fig.6).	The	lesions	can	affect	all	the	mentioned	struc-
tures,	 concern	 only	 the	 frontal	 and/or	 temporal	 lobes,	 or	
can	be	marked	better	 on	 left	 or	 right	 side	 [23].	According	
to	some	authors,	the	differences	in	SPECT	(lower	perfusion	
in	frontal	lobes	and	/or	anterior	temporal	lobes	in	FTD,	and	
parietal	 lobes	 and	posterior	part	 of	 temporal	 lobes	 in	AD)	
allow	an	almost	100%	sure	diagnosis	[24].	
Examinations	 using	 FDG-PET	 show	 decrease	 in	 glucose	
metabolism	in	frontal	and/or	temporal	lobes	[25,	26].	It	also	
presents	 differences	 according	 to	 clinical	 variant	 of	 FTD.	
Diehl	et	al.	(2004)	found	in	frontal	FTD	symmetrical	hypo-
metabolism	of	 glucose	 in	 frontal	 lobes	with	 spared	motor	
cortex,	while	 in	 semantic	 variant	 the	 hypometabolism	of	
glucose	was	observed	only	in	the	whole	left	temporal	lobe	
and	pole	of	the	right	temporal	lobe	[27].
3. Metabolitic examinations- H1 MRS spectroscopy, single-voxel 
method
Magnetic	 Resonance	 Spectroscopy	 is	 an	 exponent	 of	
metabolic	processes	in	cerebral	tissue	by	showing	abnor-
mal	 spectrum	 from	 frontal	 and	 temporal	 parts,	 with	
NAA	 lowering	 (neuron	 indicator)	 and	mI	 concentration	
(gliosis	 indicators)	 (fig.	7/8).	 The	 spectra	 are	 similar	 in	
Alzheimer’s	 disease	 but	 their	 typical	 location	 is	 diffe-
rent.	In	some	cases,	mainly	with	coexistence	of	ischemic	
lesions,	higher	lactate	peaks	can	also	be	shown.	Ernst	et	




within	 the	 frontal	 lobes;	 in	Alzheimer’s	 disease	 similar	
spectra	 are	 present	 around	 temporo-parietal	 areas	 [28].	
Kantarci	 et	 al.	 having	 examined	AD,	FTD,	DLB	and	VaD	
patients	 using	 the	MR	 spectroscopy	 prove	 that	NAA/Cr	
is	most	 lowered	 in	patients	with	AD,	FTD	and	VaD.	The	




In	 spite	 of	many	 diagnostic	methods,	 the	 FTD	 diagnosis	
presents	various	difficulties.
Only	complex	imaging	diagnostics	and	cooperation	of	neuro-
logist,	 neuropsychologist	 and	 radiologist	 allows	 reaching	
the	final	diagnosis.	
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